Orgenesis
is a Maryland-based biotechnology company that researches and develops cell and gene therapies for the treatment of a wide range of diseases... Read moreOrgenesis
is a Maryland-based biotechnology company that researches and develops cell and gene therapies for the treatment of a wide range of diseases... Read more
News
Mar 26, 2026
FinanzNachrichten
Orgenesis: Reportable, Inc.: Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio
Aug 19, 2025
TipRanks
Orgenesis: Orgenesis Faces Multiple Leadership Resignations in August
Mar 06, 2025
FinanzNachrichten
Orgenesis: Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies
Mar 06, 2025
PR-Inside
Press Release: Orgenesis : Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, ...
Nov 13, 2024
centralcharts
Press Release: Orgenesis : Orgenesis Provides Third Quarter 2024 Business Update
Nov 13, 2024
Owler
Orgenesis, Inc.: Orgenesis's revenue changed from $662K in Jun 2024 to $899K in Sep 2024
Oct 21, 2024
GlobalNewswire
Press Release: Orgenesis : Orgenesis Commences Trading on OTCQX Best Market
Sep 24, 2024
Benzinga
Orgenesis: Why Orgenesis (ORGS) Stock Is Down 23% Today
Sep 23, 2024
Citybizlist
Orgenesis: Orgenesis Announces Reverse Stock Split
Sep 03, 2024
BioPharma-Reporter
Orgenesis: Orgenesis touts early clinical promise of CAR-T therapy with decentralized production in mind
